PHase IV Clinical Trial of Ceftriaxone Sodium and Sulbactam Sodium for Injection (CRO-SBT)
Status:
Completed
Trial end date:
2017-05-27
Target enrollment:
Participant gender:
Summary
To evaluate the safety and efficacy of treatment of children with acute bacterial infection
disease with Ceftriaxone Sodium and Sulbactam Sodium for Injection in the condition of widely
used, and provide the basis of adjusting the dosage regimen for children in particular.